MUTTA

Welcome to the Brand page for “MUTTA”, which is offered here for Multitarget, multiepitope, multivalent antibody technology platform used to incorporate multiple target antigen binders into a single antibody, multi-specific reagent antibodies for medical diagnosis purposes;printed educational and informational publications related to cancer, pamphlets, newsletters, guides;multitarget, multiepitope, multivalent antibody technology platform used to incorporate multiple target antigen binders into a single antibody, multi-specific therapeutic antibodies for scientific and medical research;providing healthcare information regarding cancer drugs and cancer treatment;providing prescription drug research information relating to cancer drugs;.

Its status is currently believed to be active. Its class is unavailable. “MUTTA” is believed to be currently owned by “AARVIK THERAPEUTICS, INC.”